MASIMO CORP 8-K

What Happened

• Masimo Corporation (MASI) filed an 8-K on January 12, 2026 furnishing a press release with select preliminary financial results for the fourth quarter and full-year ended January 3, 2026. The company said these figures are based on current expectations and may be adjusted following customary annual audit procedures. Management will discuss the complete fourth-quarter and full-year 2025 results after market close on Thursday, February 26, 2026.
• At the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, Masimo’s CEO and its EVP & Chief Financial Officer reviewed the same preliminary results. The company also made supplemental fiscal 2025 financial materials and a discussion of non-GAAP measures available to investors.

Key Details

• Filing date: January 12, 2026 (Form 8-K).
• Reporting period: fourth quarter and fiscal year ended January 3, 2026.
• Management will report final audited results and discuss them after market close on February 26, 2026.
• Exhibits furnished: Press release (Exhibit 99.1) and 2025 supplemental earnings presentation including non-GAAP discussion (Exhibit 99.2).
• EVP & CFO who signed the filing: Micah Young.

Why It Matters

• This gives investors an early view of Masimo’s Q4 and full-year 2025 earnings trends before audited results are released. Preliminary figures can affect short-term stock reactions but may change after audit adjustments.
• The supplemental presentation and non-GAAP explanations are useful for understanding management’s view of adjusted results and which items may affect comparisons to prior periods.
• Retail investors should watch the February 26, 2026 post-close release and accompanying commentary for the finalized revenue, earnings, and any adjustments to the preliminary figures.